Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,954 | 17,080 | 10,080 | 10,843 | 9,390 |
| Receivables | 182,242 | 193,890 | 106,010 | 96,965 | 92,061 |
| Inventories | 132,519 | 126,270 | 92,410 | 91,428 | 75,357 |
| Income taxes - deferred | 20,770 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 41,470 | 26,880 | 28,182 | 21,727 |
| TOTAL | $369,668 | $378,710 | $235,380 | $227,418 | $198,535 |
| Non-Current Assets | |||||
| PPE Net | 119,032 | 125,940 | 82,130 | 78,678 | 71,862 |
| Investments And Advances | 0 | 1,160 | 6,170 | 18,092 | 7,432 |
| Intangibles | 90,970 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 66,608 | 163,030 | 43,600 | 27,688 | 7,096 |
| TOTAL | $276,610 | $290,130 | $131,900 | $124,458 | $86,390 |
| Total Assets | $646,278 | $668,860 | $367,290 | $351,876 | $284,925 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,656 | 10,410 | 670 | 930 | 1,058 |
| Accounts payable and accrued liabilities | 62,965 | 64,730 | 26,700 | 32,385 | 21,262 |
| Accrued Expenses | 52,354 | 74,000 | 33,740 | 24,825 | 23,717 |
| Other current liabilities | 47,430 | 41,810 | 27,390 | 27,715 | 24,630 |
| TOTAL | $189,308 | $202,520 | $97,240 | $100,782 | $79,139 |
| Non-Current Liabilities | |||||
| Long Term Debt | 203,360 | 239,210 | 42,330 | 38,952 | 6,721 |
| TOTAL | $212,352 | $246,220 | $55,710 | $54,417 | $22,278 |
| Total Liabilities | $401,660 | $448,740 | $152,960 | $155,199 | $101,417 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 12,460 | 12,420 | 12,421 | 12,321 |
| Retained earnings | 231,821 | 200,990 | 189,830 | 167,182 | 151,003 |
| Other shareholders' equity | -13,801 | -5,170 | 560 | 4,648 | 5,117 |
| TOTAL | $244,618 | $220,110 | $214,330 | $196,677 | $183,508 |
| Total Liabilities And Equity | $646,278 | $668,850 | $367,290 | $351,876 | $284,925 |